Inotiv, Inc. (NOTV)
USD 1.5
(6.03%)
USD 1.5
(6.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 382.14 Million USD | 3.85% |
| 2022 | 367.97 Million USD | 943.43% |
| 2021 | 35.26 Million USD | 0.74% |
| 2020 | 35 Million USD | 118.41% |
| 2019 | 16.02 Million USD | 82.01% |
| 2018 | 8.8 Million USD | 112.45% |
| 2017 | 4.14 Million USD | -16.47% |
| 2016 | 4.96 Million USD | 12.82% |
| 2015 | 4.39 Million USD | -12.67% |
| 2014 | 5.03 Million USD | -17.5% |
| 2013 | 6.1 Million USD | -20.04% |
| 2012 | 7.63 Million USD | 14.9% |
| 2011 | 6.64 Million USD | -28.19% |
| 2010 | 9.25 Million USD | -16.24% |
| 2009 | 11.04 Million USD | -15.4% |
| 2008 | 13.05 Million USD | 13.61% |
| 2007 | 11.49 Million USD | -17.06% |
| 2006 | 13.85 Million USD | -6.74% |
| 2005 | 14.85 Million USD | -12.95% |
| 2004 | 17.07 Million USD | 6.18% |
| 2003 | 16.07 Million USD | 111.9% |
| 2002 | 7.58 Million USD | 116.76% |
| 2001 | 3.5 Million USD | -40.69% |
| 2000 | 5.9 Million USD | 118.6% |
| 1999 | 2.7 Million USD | 1250.0% |
| 1998 | 200 Thousand USD | -96.43% |
| 1997 | 5.6 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 406.52 Million USD | 6.38% |
| 2024 Q3 | 415.35 Million USD | 4.74% |
| 2024 Q2 | 396.56 Million USD | -2.45% |
| 2023 FY | 382.14 Million USD | 3.85% |
| 2023 Q4 | 382.14 Million USD | -3.47% |
| 2023 Q3 | 395.89 Million USD | 0.93% |
| 2023 Q2 | 392.25 Million USD | 1.33% |
| 2023 Q1 | 387.09 Million USD | 5.19% |
| 2022 Q1 | 242.63 Million USD | 588.02% |
| 2022 Q3 | 346.56 Million USD | 10.18% |
| 2022 Q4 | 367.97 Million USD | 6.18% |
| 2022 FY | 367.97 Million USD | 943.43% |
| 2022 Q2 | 314.54 Million USD | 29.63% |
| 2021 Q4 | 35.26 Million USD | 23.35% |
| 2021 FY | 35.26 Million USD | 0.74% |
| 2021 Q3 | 28.59 Million USD | -13.48% |
| 2021 Q2 | 33.04 Million USD | -5.51% |
| 2021 Q1 | 34.97 Million USD | -0.1% |
| 2020 Q3 | 33.85 Million USD | 1.25% |
| 2020 Q1 | 31.09 Million USD | 94.0% |
| 2020 Q2 | 33.44 Million USD | 7.55% |
| 2020 Q4 | 35 Million USD | 3.39% |
| 2020 FY | 35 Million USD | 118.41% |
| 2019 FY | 16.02 Million USD | 82.01% |
| 2019 Q4 | 16.02 Million USD | 15.51% |
| 2019 Q3 | 13.87 Million USD | 36.95% |
| 2019 Q2 | 10.13 Million USD | 17.91% |
| 2019 Q1 | 8.59 Million USD | -2.42% |
| 2018 Q4 | 8.8 Million USD | 206.94% |
| 2018 FY | 8.8 Million USD | 112.45% |
| 2018 Q3 | 2.86 Million USD | -23.27% |
| 2018 Q2 | 3.73 Million USD | 4.94% |
| 2018 Q1 | 3.56 Million USD | -14.04% |
| 2017 Q2 | 4.64 Million USD | 14.29% |
| 2017 FY | 4.14 Million USD | -16.47% |
| 2017 Q1 | 4.06 Million USD | -18.08% |
| 2017 Q3 | 3.99 Million USD | -13.97% |
| 2017 Q4 | 4.14 Million USD | 3.7% |
| 2016 Q2 | 4.9 Million USD | -0.14% |
| 2016 Q1 | 4.9 Million USD | 11.6% |
| 2016 Q4 | 4.96 Million USD | -6.48% |
| 2016 FY | 4.96 Million USD | 12.82% |
| 2016 Q3 | 5.3 Million USD | 8.26% |
| 2015 Q2 | 4.73 Million USD | -10.3% |
| 2015 Q4 | 4.39 Million USD | -2.18% |
| 2015 Q1 | 5.27 Million USD | 4.83% |
| 2015 Q3 | 4.49 Million USD | -5.05% |
| 2015 FY | 4.39 Million USD | -12.67% |
| 2014 Q2 | 5.18 Million USD | -0.46% |
| 2014 Q3 | 5.35 Million USD | 3.26% |
| 2014 Q4 | 5.03 Million USD | -5.87% |
| 2014 Q1 | 5.2 Million USD | -14.73% |
| 2014 FY | 5.03 Million USD | -17.5% |
| 2013 Q4 | 6.1 Million USD | -1.96% |
| 2013 FY | 6.1 Million USD | -20.04% |
| 2013 Q3 | 6.22 Million USD | -12.17% |
| 2013 Q2 | 7.08 Million USD | 2.19% |
| 2013 Q1 | 6.93 Million USD | -9.13% |
| 2012 Q2 | 8.04 Million USD | 15.73% |
| 2012 Q4 | 7.63 Million USD | -9.3% |
| 2012 Q3 | 8.41 Million USD | 4.66% |
| 2012 FY | 7.63 Million USD | 14.9% |
| 2012 Q1 | 6.94 Million USD | 4.59% |
| 2011 Q4 | 6.64 Million USD | 20.3% |
| 2011 Q1 | 8.83 Million USD | -4.53% |
| 2011 Q2 | 7.81 Million USD | -11.56% |
| 2011 Q3 | 5.52 Million USD | -29.3% |
| 2011 FY | 6.64 Million USD | -28.19% |
| 2010 Q3 | 9.69 Million USD | -4.41% |
| 2010 FY | 9.25 Million USD | -16.24% |
| 2010 Q2 | 10.14 Million USD | -6.82% |
| 2010 Q1 | 10.88 Million USD | -1.48% |
| 2010 Q4 | 9.25 Million USD | -4.56% |
| 2009 Q4 | 11.04 Million USD | -5.9% |
| 2009 Q2 | 12.15 Million USD | -0.97% |
| 2009 FY | 11.04 Million USD | -15.4% |
| 2009 Q1 | 12.27 Million USD | -6.02% |
| 2009 Q3 | 11.73 Million USD | -3.41% |
| 2008 Q2 | 13.07 Million USD | 21.18% |
| 2008 FY | 13.05 Million USD | 13.61% |
| 2008 Q1 | 10.79 Million USD | -6.12% |
| 2008 Q3 | 11.85 Million USD | -9.35% |
| 2008 Q4 | 13.05 Million USD | 10.16% |
| 2007 Q2 | 13.31 Million USD | 1.84% |
| 2007 Q4 | 11.49 Million USD | -0.18% |
| 2007 Q3 | 11.51 Million USD | -13.55% |
| 2007 FY | 11.49 Million USD | -17.06% |
| 2007 Q1 | 13.07 Million USD | -5.63% |
| 2006 Q3 | 14.94 Million USD | 7.09% |
| 2006 Q4 | 13.85 Million USD | -7.28% |
| 2006 Q1 | 15.84 Million USD | 6.66% |
| 2006 Q2 | 13.95 Million USD | -11.94% |
| 2006 FY | 13.85 Million USD | -6.74% |
| 2005 Q4 | 14.85 Million USD | 3.9% |
| 2005 Q2 | 13.91 Million USD | -22.46% |
| 2005 Q1 | 17.94 Million USD | 5.14% |
| 2005 Q3 | 14.3 Million USD | 2.76% |
| 2005 FY | 14.85 Million USD | -12.95% |
| 2004 Q3 | 17.57 Million USD | 3.04% |
| 2004 FY | 17.07 Million USD | 6.18% |
| 2004 Q4 | 17.07 Million USD | -2.88% |
| 2004 Q1 | 17.91 Million USD | 11.43% |
| 2004 Q2 | 17.06 Million USD | -4.77% |
| 2003 Q1 | 12.62 Million USD | 66.43% |
| 2003 Q4 | 16.07 Million USD | 8.88% |
| 2003 FY | 16.07 Million USD | 111.9% |
| 2003 Q3 | 14.76 Million USD | 14.65% |
| 2003 Q2 | 12.87 Million USD | 1.99% |
| 2002 Q1 | 3.76 Million USD | 7.5% |
| 2002 Q3 | 7.05 Million USD | 24.65% |
| 2002 Q4 | 7.58 Million USD | 7.55% |
| 2002 FY | 7.58 Million USD | 116.76% |
| 2002 Q2 | 5.66 Million USD | 50.41% |
| 2001 Q1 | 6.1 Million USD | 3.35% |
| 2001 Q4 | 3.5 Million USD | -11.9% |
| 2001 FY | 3.5 Million USD | -40.69% |
| 2001 Q2 | 5.56 Million USD | -8.82% |
| 2001 Q3 | 3.97 Million USD | -28.57% |
| 2000 Q1 | 5 Million USD | 85.19% |
| 2000 Q2 | 5.51 Million USD | 10.26% |
| 2000 Q3 | 5.3 Million USD | -3.81% |
| 2000 Q4 | 5.9 Million USD | 11.3% |
| 2000 FY | 5.9 Million USD | 118.6% |
| 1999 Q3 | 2.8 Million USD | 3.7% |
| 1999 Q4 | 2.7 Million USD | -3.57% |
| 1999 FY | 2.7 Million USD | 1250.0% |
| 1999 Q1 | 2 Million USD | 900.0% |
| 1999 Q2 | 2.7 Million USD | 35.0% |
| 1998 Q3 | -2.6 Million USD | 7.14% |
| 1998 FY | 200 Thousand USD | -96.43% |
| 1998 Q2 | -2.8 Million USD | 12.5% |
| 1998 Q1 | -3.2 Million USD | -159.15% |
| 1998 Q4 | 200 Thousand USD | 107.69% |
| 1997 FY | 5.6 Million USD | 0.0% |
| 1997 Q4 | 5.41 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -39.45 Million USD | 1068.643% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | 6561.725% |
| Aspira Women's Health Inc. | -331 Thousand USD | 115552.87% |
| Biodesix, Inc. | 34.3 Million USD | -1013.91% |
| BioNexus Gene Lab Corp. | -5.79 Million USD | 6693.39% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | 30845.794% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | 30845.794% |
| Bionano Genomics, Inc. | 34.88 Million USD | -995.548% |
| CareDx, Inc | -47.97 Million USD | 896.542% |
| Check-Cap Ltd. | -24.75 Million USD | 1643.662% |
| Castle Biosciences, Inc. | -83.53 Million USD | 557.494% |
| DarioHealth Corp. | -7.54 Million USD | 5162.917% |
| Exact Sciences Corporation | 1.94 Billion USD | 80.396% |
| Fulgent Genetics, Inc. | -82.56 Million USD | 562.841% |
| Guardant Health, Inc. | 220.22 Million USD | -73.525% |
| ICON Public Limited Company | 3.56 Billion USD | 89.266% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 22.634% |
| Illumina, Inc. | 1.21 Billion USD | 68.521% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | 7134.292% |
| iSpecimen Inc. | -2.14 Million USD | 17895.71% |
| Standard BioTools Inc. | 46.5 Million USD | -721.72% |
| MDxHealth SA | 18.88 Million USD | -1923.558% |
| 23andMe Holding Co. | -141.37 Million USD | 370.314% |
| Medpace Holdings, Inc. | -103.32 Million USD | 469.844% |
| Myriad Genetics, Inc. | 88.1 Million USD | -333.767% |
| Mainz Biomed B.V. | 349.85 Thousand USD | -109130.681% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | 15765.029% |
| NeoGenomics, Inc. | 269.19 Million USD | -41.962% |
| Neogen Corporation | 735.62 Million USD | 48.051% |
| Natera, Inc. | -200.1 Million USD | 290.977% |
| OpGen, Inc. | 11.89 Million USD | -3113.528% |
| OPKO Health, Inc. | 230.68 Million USD | -65.66% |
| Psychemedics Corporation | 334 Thousand USD | -114315.868% |
| Prenetics Global Limited | -43.33 Million USD | 981.806% |
| Prenetics Global Limited | -43.33 Million USD | 981.806% |
| Precipio, Inc. | -386 Thousand USD | 99102.332% |
| Personalis, Inc. | -8.02 Million USD | 4863.762% |
| RadNet, Inc. | 1.14 Billion USD | 66.728% |
| Sera Prognostics, Inc. | -2.02 Million USD | 18999.555% |
| Sotera Health Company | 2.02 Billion USD | 81.132% |
| Neuronetics, Inc. | 2.79 Million USD | -13562.817% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 2591.68% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 2591.68% |
| Trinity Biotech plc | 63.73 Million USD | -499.581% |
| T2 Biosystems, Inc. | 33.8 Million USD | -1030.317% |
| Twist Bioscience Corporation | -192.4 Million USD | 298.621% |
| Exagen Inc. | -12.77 Million USD | 3092.084% |